Business Wire Feed
Lantern Pharma to Debut Public Demonstration of withZeta.ai – A Platform to Conquer Rare Cancers on April 30 Following AACR 2026 Scientific Debut
CEO Panna Sharma to Lead Live, Unscripted Platform Walkthrough in Two Interactive Sessions on April 30, 2026 — Open to Investors, Researchers, and the Global Biomedical Community Registration Link & Details Can be Accessed Below more...
UnitedHealthcare Champions Industry Effort to Standardize Prior Authorization Requirements
Company expects more than 70% of prior authorization volume to be part of new standardized submission process by year‑end Latest in continuing series of company actions to simplify and ease administrative requirements--(BUSINESS WIRE)--UnitedHealthcare today announced more...
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast
BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2026 financial results before market opening on Wednesday, May 6, 2026. The Company will host a conference call and webcast at more...
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company
Expands Options for Cash-Paying Patients to Access the Nation’s #1 Prescribed Oral Blood ThinnerPRINCETON, N.J.--(BUSINESS WIRE)--$BMY #Eliquis--The Bristol Myers Squibb-Pfizer (BMS NYSE: BMY) — (Pfizer NYSE: PFE) Alliance today announced the launch of a collaboration more...
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with more...
Arrowhead Pharmaceuticals Receives Positive CHMP Opinion Recommending Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) in Europe
– If confirmed by the European Commission, REDEMPLO would be the first and only siRNA medicine authorized in the EU for both genetically confirmed and clinically diagnosed adult patients with FCS – People living with more...
City of Hope and UC Berkeley Researchers Teach AI to Spot Cancer Risk by Squeezing Individual Breast Cells
Scientists discover that a cell's 'mechanical age' can effectively signal cancer risk.LOS ANGELES--(BUSINESS WIRE)--Researchers at City of Hope®, a cancer research and treatment organization, and the University of California, Berkeley, have created a novel microfluidic more...
Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced the company will report financial results for the more...
Guardian Pharmacy Services, Inc. to Participate in the Bank of America 2026 Healthcare Conference
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) will be attending the Bank of America 2026 Healthcare Conference in Las Vegas on Wednesday, May 13, 2026. Fred Burke, President and Chief Executive Officer, will participate in more...
Reflow Medical Announces U.S. Launch of Next-Generation Cora Flex® and Cora Force® Torqueable Microcatheters
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--#coraflex--Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, today announced the U.S. market launch of its next-generation Cora Flex® and Cora Force® Torqueable Microcatheters, now more...
Kenvue to Announce First Quarter 2026 Results on May 7, 2026
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) will announce its first quarter 2026 financial results before the market opens on May 7, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a more...
Jamieson Wellness Inc. Announces Date of First Quarter 2026 Financial Results and Conference Call
TORONTO--(BUSINESS WIRE)--Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX:JWEL) announced today that the Company will release its first quarter 2026 financial results after the market close on Thursday, May 7, 2026. The Company will more...
Acadia Healthcare Appoints David Duckworth as Interim Chief Financial Officer
Reaffirms Financial Guidance for First Quarter and Full Year 2026FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced the appointment of David Duckworth, former Chief Financial Officer of Acadia, as more...
CareTrust REIT Sets First Quarter Earnings Call for Friday, May 8, 2026
DANA POINT, Calif.--(BUSINESS WIRE)--CareTrust REIT, Inc. (NYSE:CTRE) announced today that it plans to release its first quarter 2026 financial results after the U.S. markets close on Thursday, May 7, 2026. Representatives of CareTrust REIT’s management more...
Vir Biotechnology to Host Conference Call for First Quarter 2026 Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that it will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT on Wednesday, May 6 to provide a corporate update and discuss more...
Owlet to Report First Quarter 2026 Financial Results on May 7, 2026
LEHI, Utah--(BUSINESS WIRE)--$owlt #babymonitor--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, plans to announce first quarter 2026 financial results after market close on Thursday, May 7, 2026. Owlet’s President, more...
Personalis to Announce First Quarter 2026 Financial Results
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that it will release its first quarter 2026 financial results on Thursday, May 7, 2026. In conjunction with the more...
Karius, Inc. Announces Collaboration to Extend Access to Infectious Disease Diagnostics
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Karius, Inc. (“Karius”) and Mayo Clinic Laboratories today announced a collaboration to make Karius’s advanced metagenomic infectious disease diagnostic offerings, the Karius Spectrum™ and the Karius Focus™ | BAL tests, available to more...
Establishment Labs® to Announce First Quarter 2026 Financial Results on May 6
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter more...
Covista Medical Schools Achieve 97% Combined First-Time Residency Attainment Rate
AUC and Ross graduates match into family medicine, emergency medicine, psychiatry and other high-need specialties across 42 states.CHICAGO--(BUSINESS WIRE)--Covista (NYSE: CVSA), America’s largest healthcare educator, today announced a combined 97% first-time residency attainment rate* for more...
Almanac Health Raises $10 Million to Empower Clinicians Across Specialties with Safe, Research-Validated Clinical AI
Seed round led by F-Prime, with participation from General Catalyst and Lightspeed Venture Partners. General Catalyst previously led the pre-seed round.BOSTON--(BUSINESS WIRE)--Almanac Health, a research-validated clinical AI platform and evidence-based clinical decision support company founded more...
Verastem Oncology to Report First Quarter 2026 Financial Results on May 7, 2026
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that the Company will host a conference call and webcast to discuss its first more...
GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents
Mangaciclanol, if approved, could transform contrast-enhanced MR imaging by offering an alternative to - or even replacing - gadolinium-based MRI agents A manganese-based MRI contrast agent could address concerns with gadolinium-based contrast agents around retention more...
Croma Pharma Launches AI-Driven Tech Venture to Revolutionize Aesthetic Medicine via Clinicore Platform
New structure to drive AI-powered innovation and international expansionLEOBENDORF, Austria--(BUSINESS WIRE)--#aestheticmedicine--Croma Pharma has launched a strategic joint venture to accelerate the development of Clinicore, its premium digital solution for aesthetic practices. This dedicated entity will more...
Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026
– Separate poster will feature long-term safety and tolerability data from STARS clinical trial program of apraglutide in adults with SBS who are dependent on parenteral support (PS) – – Linaclotide data presentations highlight efficacy more...